# UBTD2

## Overview
UBTD2, or ubiquitin domain containing 2, is a gene that encodes a protein involved in various cellular processes, including protein degradation, cell cycle regulation, and apoptosis. The protein, also known as DC-UbP, is characterized by its unique structure comprising an N-terminal domain and a C-terminal ubiquitin-like (UbL) domain, which facilitate its role as a ubiquitin shuttle protein. This protein is active in both the cytoplasm and nucleus, where it influences cellular homeostasis and stress responses. UBTD2 is implicated in gene silencing and chromatin interactions, with potential roles in brain development and adipogenesis. It interacts with key proteins in the ubiquitination pathway, such as the ubiquitin-activating enzyme E1 and the deubiquitinating enzyme USP5, highlighting its significance in maintaining cellular ubiquitination levels (Cai2019H3K27me3-rich; Song2014A; Song2010Solution).

## Structure
The UBTD2 protein, also known as DC-UbP, is characterized by its unique molecular structure, which includes two distinct domains: an N-terminal domain and a C-terminal ubiquitin-like (UbL) domain. The N-terminal domain, referred to as DC-UbP_N, exhibits a novel structural fold that is not homologous to any known structures in the Protein Data Bank (PDB), suggesting it represents a unique domain structure (Song2010Solution). This domain acts as a ubiquitin-binding domain (UBD) with low affinity and features an aaabb structural pattern with a short helix at the C-terminus. The N-terminal region, particularly residues 14-46, is extended and contributes to the stability of the overall structure (Song2010Solution).

The C-terminal UbL domain is crucial for protein-protein interactions, which are essential in the ubiquitination processes. The combination of the UbL and UBD domains in UBTD2 is thought to play a significant role in regulating protein ubiquitination and the delivery of ubiquitinated substrates in eukaryotic cells (Song2010Solution). While specific post-translational modifications and splice variant isoforms are not detailed in the provided context, such modifications could potentially regulate the function of UBTD2.

## Function
UBTD2 (ubiquitin domain containing 2) is involved in various cellular processes, including protein degradation, cell cycle regulation, and apoptosis. The protein encoded by UBTD2 contains a ubiquitin-like domain, suggesting its role in ubiquitin-mediated pathways, which are crucial for maintaining cellular homeostasis and stress responses. UBTD2 is active in both the cytoplasm and nucleus, where it influences these processes (Cai2019H3K27me3-rich).

In the context of chromatin interactions, UBTD2 is implicated in gene silencing. Disruption of H3K27me3-rich regions, which interact with UBTD2, can lead to changes in gene expression, affecting cell differentiation and potentially contributing to tumor growth (Cai2019H3K27me3-rich). UBTD2 has also been associated with brain development, as it is expressed in dendritic cells and the mouse brain, indicating a potential role in brain malformations (Krutzke2015Array‐based).

In adipogenesis, UBTD2 appears to play a negative regulatory role, as its expression is higher in pigs with high lean meat mass, suggesting its involvement in fat and muscle trait regulation (Wang2024Constructing). These functions highlight UBTD2's significance in various biological processes and its potential impact on health and disease.

## Clinical Significance
The UBTD2 gene has been implicated in various clinical conditions, particularly in relation to brain malformations and cancer. A study identified a duplication of the chromosomal region 5q35.1, which includes the UBTD2 gene, in a fetus diagnosed with Dandy-Walker malformation. This suggests a potential link between UBTD2 and brain development anomalies, although the specific clinical significance of UBTD2 mutations or expression changes in this context remains unclear (Krutzke2015Array‐based).

In cancer research, UBTD2 has been associated with gene silencing mechanisms. A study demonstrated that the excision of a chromatin interaction region led to the upregulation of UBTD2, indicating its involvement in gene expression regulation. This alteration in expression could potentially affect cell differentiation and tumor growth, although the clinical implications of these changes are not fully detailed (Cai2019H3K27me3-rich).

Despite these findings, the specific role of UBTD2 in disease progression and its potential as a therapeutic target require further investigation. Current studies highlight its involvement in critical cellular processes, but the direct impact of UBTD2 mutations or expression alterations on clinical outcomes is not yet fully understood.

## Interactions
UBTD2, also known as DC-UbP, is involved in the ubiquitination pathway and interacts with several key proteins. It contains a ubiquitin-like (UbL) domain and a ubiquitin-binding domain (UBD), which facilitate its role as a ubiquitin shuttle protein. UBTD2 interacts with the ubiquitin-activating enzyme E1 (UbE1) and the deubiquitinating enzyme USP5. These interactions occur through specific domains: the tandem UBA domains of USP5 bind to the C-terminal UbL domain of UBTD2, while the C-terminal Ub-fold domain (UFD) of UbE1 also interacts with the same region of UBTD2. These interactions are crucial for modulating cellular ubiquitination levels, as UBTD2 enhances the association between UbE1 and USP5, promoting ubiquitination processes (Song2014A).

UBTD2's interaction with USP5 and UbE1 does not significantly alter their enzymatic activities, but it facilitates their association, suggesting a mediating role in the ubiquitination and deubiquitination processes. Mutations on the UbL surface of UBTD2 can reduce its interaction with USP5, indicating the importance of specific residues for binding (Song2014A). These interactions exemplify UBTD2's role in maintaining cellular homeostasis by linking ubiquitination and deubiquitination processes (Song2014A).


## References


1. (Cai2019H3K27me3-rich) H3K27me3-rich genomic regions can function as silencers to repress gene expression via chromatin interactions. This article has 179 citations.

[2. (Wang2024Constructing) Chao Wang, Choulin Chen, Bowen Lei, Shenghua Qin, Yuanyuan Zhang, Kui Li, Song Zhang, and Yuwen Liu. Constructing erna-mediated gene regulatory networks to explore the genetic basis of muscle and fat-relevant traits in pigs. Genetics Selection Evolution, April 2024. URL: http://dx.doi.org/10.1186/s12711-024-00897-4, doi:10.1186/s12711-024-00897-4. This article has 0 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1186/s12711-024-00897-4)

[3. (Krutzke2015Array‐based) Sophia K. Krutzke, Hartmut Engels, Andrea Hofmann, Madita M. Schumann, Kirsten Cremer, Alexander M. Zink, Alina Hilger, Michael Ludwig, Ulrich Gembruch, Heiko Reutter, and Waltraut M. Merz. Array‐based molecular karyotyping in fetal brain malformations: identification of novel candidate genes and chromosomal regions. Birth Defects Research Part A: Clinical and Molecular Teratology, 106(1):16–26, December 2015. URL: http://dx.doi.org/10.1002/bdra.23458, doi:10.1002/bdra.23458. This article has 14 citations.](https://doi.org/10.1002/bdra.23458)

[4. (Song2014A) Ai-Xin Song, Hui Yang, Yong-Guang Gao, Chen-Jie Zhou, Yu-Hang Zhang, and Hong-Yu Hu. A ubiquitin shuttle dc-ubp/ubtd2 reconciles protein ubiquitination and deubiquitination via linking ube1 and usp5 enzymes. PLoS ONE, 9(9):e107509, September 2014. URL: http://dx.doi.org/10.1371/journal.pone.0107509, doi:10.1371/journal.pone.0107509. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0107509)

[5. (Song2010Solution) Ai‐Xin Song, Chen‐Jie Zhou, Xiao Guan, Kong‐Hung Sze, and Hong‐Yu Hu. Solution structure of the n‐terminal domain of dc‐ubp/ubtd2 and its interaction with ubiquitin. Protein Science, 19(5):1104–1109, April 2010. URL: http://dx.doi.org/10.1002/pro.386, doi:10.1002/pro.386. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/pro.386)